Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

PositiveID Corp. (PSID) Expanding Their Biological Detection Capabilities

|Includes: PositiveID Corp. (PSID)

On Wednesday, PositiveID Corp. announced that the Company is expanding their biological detection capabilities to include the detection of H5N1, or avian flu. This is amid signs that a mutant strain of the deadly bird flu virus is spreading overseas. Via their MicroFluidic Systems (MFS) subsidiary, PositiveID has the biological capability to detect virtually any virus, bacteria, or toxin in an environmental or clinical environment.

The Company is completing a test to identify, cost-effectively and quickly, the mutant strain of H5N1. They expect to have their laboratory development completed in the fourth quarter of this year. PositiveID has created and proven highly modular, smart, “plug and play” components and integrated solutions for practical, high utility biological analysis applications. Their products are able to process complex samples rapidly, with a high level of sensitivity and accuracy.

Mr. William J. Caragol, PositiveID’s CEO, said, “Our biological sample preparation and detection platform is highly adaptable, and the process of expanding our detection capabilities to test for new viruses and bacteria can be accomplished in a very short period of time. Therefore, not only can we be ready very quickly to test for this mutant strain of bird flu, but we can be ready for future outbreaks, whether it is swine flu or some other pandemic virus. Our unique solutions reduce costs, increase reliability and produce timely results, which is of critical importance when diagnosing pandemic viruses to improve outbreak containment measures.”

The United Nations is urging people to be ready against a possible but major resurgence of the avian flu. The H5N1 virus has infected 565 people since it first appeared in 2003, killing 331, according to World Health Organization figures. Since 2003, H5N1 has killed or forced the culling of more than 400 million domestic poultry. In addition, it has caused an estimated $20 billion of economic damage around the world before it was eliminated from most of the countries infected at its height in 2006. Of the few avian influenza viruses that have crossed the species barrier to infect humans, the mutant strain of bird flu has caused the largest number of detected cases of severe disease and death in humans, according to the U.S. Centers for Disease Control and Prevention.

Trading on the OTC Bulletin Board, PositiveID is a developer of medical technologies for diabetes management, clinical diagnostics, and bio-threat detection. Their wholly owned subsidiary, MicroFluidic Systems, focuses on the development of microfluidic systems for automated preparation of and performance of biological assays. PositiveID has their headquarters in Delray Beach, Florida.

For more information visit: PositiveIDCorp.com

Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net